p16 Expression: A marker of differentiation between childhood malignant melanomas and Spitz nevi
- 31 August 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 65 (2), 357-363
- https://doi.org/10.1016/j.jaad.2010.07.031
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Spitzoid melanomaClinics in Dermatology, 2009
- Reduced p16 and Increased Cyclin D1 and pRb Expression Are Correlated With Progression in Cutaneous Melanocytic TumorsInternational Journal of Surgical Pathology, 2009
- p16 Expression differentiates between desmoplastic Spitz nevus and desmoplastic melanomaJournal of Cutaneous Pathology, 2009
- Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic toolJournal of Cutaneous Pathology, 2009
- p16ink4a Is a Surrogate Marker for High-Risk and Malignant Cervical Lesions in the Presence of Human PapillomavirusPathobiology, 2009
- Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2009
- Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanomaPathology, 2007
- Differentiating spitzoid melanomas from Spitz nevi through CD99 expressionJournal of Cutaneous Pathology, 2006
- p16 expression in primary malignant melanoma is associated with prognosis and lymph node statusInternational Journal of Cancer, 2005
- Malignant melanoma in childhood and adolescence: Report of 13 casesJournal of the American Academy of Dermatology, 2005